Sarah K. Madden

Sarah K. Madden

Auto-generated profile, based on publicly available information

Sarah K. Madden

Yusuf Hamied Department of Chemistry

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
SMSarah K. Madden
Sarah K. Madden
AAAline Dantas de Araujo
Aline Dantas de Araujo
MGMara Gerhardt
Mara Gerhardt
DFDavid P. Fairlie
David P. Fairlie
JMJody M. Mason
Jody M. Mason
C-Myc is a transcription factor that is constitutively and aberrantly expressed in over 70% of human cancers. Its direct inhibition has been shown to trigger rapid tumor regression in mice with only mild and fully reversible side effects, suggesting this to be a viable therapeutic strategy. Here we reassess the challenges of directly targeting c-Myc, evaluate lessons learned from current inhibitors, and explore how future strategies such as miniaturisation of Omomyc and targeting E-box binding could facilitate translation of c-Myc inhibitors into the clinic.

1 June 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LWLouise J. Walport
Louise J. Walport
RHRichard J. Hopkinson
Richard J. Hopkinson
MVMelanie Vollmar
Melanie Vollmar
SMSarah K. Madden
Sarah K. Madden
CGCarina Gileadi
Carina Gileadi
CJCatrine Johansson
Catrine Johansson
The Jumonji C lysine demethylases (KDMs) are 2-oxoglutarate- and Fe(II)-dependent oxygenases. KDM6A (UTX) and KDM6B (JMJD3) are KDM6 subfamily members that catalyze demethylation of Nϵ-methylated histone 3 lysine 27 (H3K27), a mark important for transcriptional repression. Despite reports stating that UTY(KDM6C) is inactive as a KDM, we demonstrate by biochemical studies, employing MS and NMR, that UTY(KDM6C) is an active KDM. Crystallographic analyses reveal that the UTY(KDM6C) active site is highly conserved with those of KDM6B and KDM6A. UTY(KDM6C) catalyzes demethylation of H3K27 peptides in vitro, analogously to KDM6B and KDM6A, but with reduced activity, due to point substitutions involved in substrate binding. The results expand the set of human KDMs and will be of use in developing selective KDM inhibitors.

6 April 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
AKAkane Kawamura
Akane Kawamura
MMMartin Münzel
Martin Münzel
TKTatsuya Kojima
Tatsuya Kojima
CYClarence Yapp
Clarence Yapp
BBBhaskar Bhushan
Bhaskar Bhushan
CSChristopher J. Schofield
Christopher J. Schofield
The JmjC histone demethylases (KDMs) are linked to tumour cell proliferation and are current cancer targets; however, very few highly selective inhibitors for these are available. Here we report cyclic peptide inhibitors of the KDM4A-C with selectivity over other KDMs/2OG oxygenases, including closely related KDM4D/E isoforms. Crystal structures and biochemical analyses of one of the inhibitors (CP2) with KDM4A reveals that CP2 binds differently to, but competes with, histone substrates in the active site. Substitution of the active site binding arginine of CP2 to N-ɛ-trimethyl-lysine or methylated arginine results in cyclic peptide substrates, indicating that KDM4s may act on non-histone substrates. Targeted modifications to CP2 based on crystallographic and mass spectrometry analyses results in variants with greater proteolytic robustness. Peptide dosing in cells manifests KDM4A target stabilization. Although further development is required to optimize cellular activity, the results reveal the feasibility of highly selective non-metal chelating, substrate-competitive inhibitors of the JmjC KDMs.

9 December 2022 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SGSilvia Galli
Silvia Galli
LMLarry Melidis
Larry Melidis
SFSean M. Flynn
Sean M. Flynn
DVDhaval Varshney
Dhaval Varshney
ASAngela Simeone
Angela Simeone
SBShankar Balasubramanian
Shankar Balasubramanian
G-quadruplexes (G4s) are four-stranded DNA secondary structures that occur in the human genome and play key roles in transcription, replication, and genome stability. G4-specific molecular probes are of vital importance to elucidate the structure and function of G4s. The scFv antibody BG4 has been a widely used G4 probe but has various limitations, including relatively poor in vitro expression and the inability to be expressed intracellularly to interrogate G4s in live cells. To address these considerations, we describe herein the development of SG4, a camelid heavy-chain-only derived nanobody that was selected against the human Myc DNA G4 structure. SG4 exhibits low nanomolar affinity for a wide range of folded G4 structures in vitro. We employed AlphaFold combined with molecular dynamics simulations to construct a molecular model for the G4-nanobody interaction. The structural model accurately explains the role of key amino acids and Kd measurements of SG4 mutants, including arginine-to-alanine point mutations that dramatically diminish G4 binding affinity. Importantly, predicted amino acid-G4 interactions were subsequently confirmed experimentally by biophysical measurements. We demonstrate that the nanobody can be expressed intracellularly and used to image endogenous G4 structures in live cells. We also use the SG4 protein to positionally map G4s in situ and also on fixed chromatin. SG4 is a valuable, new tool for G4 detection and mapping in cells.

2 December 2014 in Epigenetics
Verified
Journal Article
Open access
SWSophie T Williams
Sophie T Williams
LWLouise J Walport
Louise J Walport
RHRichard J Hopkinson
Richard J Hopkinson
SMSarah K Madden
Sarah K Madden
RCRasheduzzaman Chowdhury
Rasheduzzaman Chowdhury
AKAkane Kawamura
Akane Kawamura
The JmjC-domain-containing 2-oxoglutarate-dependent oxygenases catalyze protein hydroxylation and Nϵ-methyllysine demethylation via hydroxylation. A subgroup of this family, the JmjC lysine demethylases (JmjC KDMs) are involved in histone modifications at multiple sites. There are conflicting reports as to the substrate selectivity of some JmjC oxygenases with respect to KDM activities. In this study, a panel of modified histone H3 peptides was tested for demethylation against 15 human JmjC-domain-containing proteins. The results largely confirmed known Nϵ-methyllysine substrates. However, the purified KDM4 catalytic domains showed greater substrate promiscuity than previously reported (i.e., KDM4A was observed to catalyze demethylation at H3K27 as well as H3K9/K36). Crystallographic analyses revealed that the Nϵ-methyllysine of an H3K27me3 peptide binds similarly to Nϵ-methyllysines of H3K9me3/H3K36me3 with KDM4A. A subgroup of JmjC proteins known to catalyze hydroxylation did not display demethylation a...

1 July 2020 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
SMSarah K. Madden
Sarah K. Madden
Laura S. ItzhakiLaura S. Itzhaki
Laura S. Itzhaki